Santa Cruz Biotechnology offers a broad range of neurexin I α monoclonal antibodies for neuroscience and cell biology research. Neurexin I α monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Neurexin I α is a crucial protein involved in synaptic function and neuronal communication, playing a significant role in the formation and maintenance of synapses. Understanding neurexin I α function is essential for investigating various neurological disorders due to its vital role in neurodevelopment and synaptic plasticity. Neurexin I α monoclonal antibodies enable detailed examination of synaptic transmission mechanisms at the molecular level. Researchers can investigate how neurexin I α influences neural circuit development and synaptic strength through precise detection methods. Advanced research with neurexin I α monoclonal antibodies helps uncover potential therapeutic targets for neurological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of complex neurological processes and potential therapeutic interventions.